Stock Analysis

Kuantum Papers Third Quarter 2025 Earnings: EPS: ₹2.40 (vs ₹4.83 in 3Q 2024)

NSEI:KUANTUM
Source: Shutterstock

Kuantum Papers (NSE:KUANTUM) Third Quarter 2025 Results

Key Financial Results

  • Revenue: ₹2.70b (down 10% from 3Q 2024).
  • Net income: ₹209.7m (down 50% from 3Q 2024).
  • Profit margin: 7.8% (down from 14% in 3Q 2024). The decrease in margin was driven by lower revenue.
  • EPS: ₹2.40 (down from ₹4.83 in 3Q 2024).
earnings-and-revenue-history
NSEI:KUANTUM Earnings and Revenue History February 13th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kuantum Papers shares are down 8.2% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 3 warning signs for Kuantum Papers you should know about.

Valuation is complex, but we're here to simplify it.

Discover if Kuantum Papers might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:KUANTUM

Kuantum Papers

Produces, markets, and sells agro and wood-based paper products in India.

Good value average dividend payer.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|37.11% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|23.535% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|1.7389999999999999% overvalued
Jonataninho
Jonataninho
Community Contributor